跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 89,696 条关于
“RB1-deficient cancers”
全部
89,696
临床试验
77,762
药物
1,923
机构
290
资讯
9,721
2个月前
ThalassaX Doses First U.S. Patient in Phase I Trial of Brain-Penetrant Aurora B Kinase Inhibitor CS231295
2年前
NXP800 Receives FDA Orphan Drug Designation for ARID1a-Deficient Ovarian Cancers
去年
Dostarlimab Shows Promise in Eliminating Need for Surgery Across Multiple dMMR Cancer Types
3年前
Repare Therapeutics' ATR Inhibitor Camonsertib Shows Promise in DNA Repair-Deficient Cancers
9个月前
Large-Scale Drug Screen Reveals Common Medicines Can Enhance CRISPR Therapy and Target DNA Repair-Deficient Cancers
去年
Circle Pharma's Novel Cyclin Inhibitor Shows Promise Against E2F-Driven Cancers in Nature Study
2年前
Saruparib Shows Promise in HRR-Deficient Breast Cancer
去年
Dana-Farber Researchers Launch Phase 1 Trial of Novel Cyclin Inhibitor for Small Cell Lung Cancer
2年前
Nivolumab and Relatlimab Show Promise in MMR-Deficient Colon Cancer
去年
Truqap plus Abiraterone and ADT Improves rPFS in PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer
第 1 页,共 973 页
上一页
下一页